- Home
- Â /Â Sientra
Sientra
Stock Price
$0.1
2024-04-24
Market Capitalization
$2.1 M
2024-04-24
Revenue
$90.5 M
FY, 2022
Sientra Summary
Company Summary
- Overview
- Sientra is a company that develops and sells medical aesthetics products. It offers silicone gel breast implants and tissue expanders for use in breast augmentation and reconstruction procedures.
- Type
- Public
- Status
- Active
- Founded
- 2003
- HQ
- Irvine, CA, US | view all locations
- Website
- http://www.sientra.com
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Denise Dajles, Chief Technical Officer
Oliver Bennett, Chief Legal, Compliance, & Corporate Development Officer
Matt Hostetler, Chief People Officer
Operating MetricsView all
Product Variations
350
FY, 2022
Sientra Financials
Summary Financials
- Revenue (Q3, 2023)
- $19.5M
- Gross profit (Q3, 2023)
- $10.0M
- Net income (Q3, 2023)
- ($14.8M)
- Cash (Q3, 2023)
- $15.0M
- EBIT (Q3, 2023)
- ($9.4M)
- Enterprise value
- $50.0M